Ethical and Deontological Issues in Psychiatry
American Journal of Psychiatry and Neuroscience
Volume 2, Issue 6, November 2014, Pages: 96-100
Received: Nov. 20, 2014; Accepted: Nov. 27, 2014; Published: Dec. 2, 2014
Views 2435      Downloads 117
Anca Livia Chirita, Department of Psychiatry, University of Medicine and Pharmacy, Craiova, Romania
Article Tools
Follow on us
General ethic principles in psychiatry are similar to those in somatic therapy, psychiatry being the medicine of the mind. The needs of the patient and society are the main focus of this medical specialty. Obtaining informed consent and cooperation can be encouraged if adequate information is disclosed to the patient from the outset. If the therapeutic measures that are being implemented (especially in case of, for instance, emergency admissions) are based on well-defined clinical data, the capacity of the patient to decide for themselves should be considered in addition to competency issues determined solely by the psychiatrist. Clinical experience has revealed that, unlike patients of other specialties, patients suffering from serious mental disorder often initially do not accept their clinical diagnosis, and subsequently may refuse much needed treatment. Temporarily, limiting the personal freedoms of the mentally ill are not just an end into itself, but an important means to ensure compliance with pharmacological and therapeutic objectives required for patient stabilization. The psychiatrist does so because, eventually, this would ideally restore the individual’s rights to liberty, freedom and independent decision-making.
Ethics, Deontology, Psychiatry
To cite this article
Anca Livia Chirita, Ethical and Deontological Issues in Psychiatry, American Journal of Psychiatry and Neuroscience. Vol. 2, No. 6, 2014, pp. 96-100. doi: 10.11648/j.ajpn.20140206.13
Petitjean F, Cordier B. Deontologie et psychiatrie. Editions Techniques, Encycl Med Chir Paris France, 37061A, 1991.
Daumezon G. Psychiatrie et ethique. Evol Psychiatr, 1989, 44:115-129.
World Psychiatric Association. Declaration of Hawaii. J Med Ethics, 1978, 4:71-73.
Thornicroft G, Tansella M. Bazele etice ale serviciilor de sănătate mintală: „cei trei ași (ACE)”. In Thornicroft G, Tansella M eds. Modelul matriceal al sănătății mintale. Editura Medicală București; 2001. p. 146-148.
World Psychiatric Association. Declaration of Hawaii/II. WPA General Assembly, Vienna, 10th July 1983.
World Psychiatric Association. Declaration of Hawaii/III (Revised at the General Assembly of Madrid); 1996.
United Nations. Protection pf persons with mental illness and improvement in mental health care. Resolution UN/GA/46/119; New York, United Nations, 17 December 1991 International Digest of Health Legislation, 43:2.
World Health Organization. Public mental health: Guidelines for the elaboration and management of national mental health programmes. Geneva; WHO Division of Mental Health and Prevention of Substance Abuse; 1996.
World Health Organization. Mental health law: ten basic principles. Geneva, WHO; 1996.
Poirier-Littre MF, Ginestet D. Legislation des essais therapeutiques. Edition Techniques, Encycl Med Chir; Paris, France 37040B, 1991.
Dahan R, Caolin C, Figea L, Kanis JA, Caolin F, Segrestaa JM. Does informed consent influence therapeutic outcome? A clinical trial of the hypnotic activity of placebo in patients admited to hospital. Br Med J; 1996, 293:363-364.
Kuipers L, Bebbington P. Working in partnership: clinicians and carers in the management of long-term mental illness. London: Heineman; 1991.
Schene A, Tessler K, Gamache G. Instruments measuring family or care giver burden in severe mental illness. Soc Psychiat and Psychiat Epidemiol; 1994; 29:228-240.
Keitner GI, Kurimay T, Wilson AK. Advances in family research and intervention. In: Christodoulou GN editor. Advance in psychiatry. 2005, Vol. 2:127-134.
Bebbington PE, Kuipers E. Schizophrenia and psychosocial stresses. In: Hirsch SR, Weinberger D eds. Schizophrenia, psychosocial aspects. Oxford UK: Blackwell; 2003. p. 615-622.
Asen E. Outcome research in family therapy. Advances in psychiatric treatment. 2002; 8:230-238.
Hooley JMR, Hiller JB. Personality and expressed emotion. J Abnorm Psychol. 2000; 109:40-44.
McFarlane WR. Multifamily groups in the treatment of psychiatric disorders. New York: Guilford; 2002.
Vixon MJ, King S, Stip E, Cormier H. Continuous performance test differences among schizophrenic outpatients living in high and low expressed emotion environments. Psychol Med. 2000; 30:1141-1153.
Ryan CE, Epstein NB, Keitner GI. Evaluating and treating families: the McMaster approach. New York: Brunner/Mazel; 2005.
Loue S, Ioan BG. Repere istorice în cercetarea pe subiecți umani. In: Astărăstoaie V, Loue S, Ioan BG eds. Etica cercetării pe subiecți umani. Iași: Editura Gr. T. Popa; 2009. p. 9-10.
Crocq MA, Macher JP, Luthringer R. Recent developments in the metodology of drug development. In: Christodoulou GN editor. Advances in Psychiatry. Vol. II, 2005, p. 95-99.
Staner L, Luthringer R, Macher JP. Effects of antidepressant drugs on sleep EEG in patients with major depression. Mechanisms and therapeutic implications. CNS Drugs, 1999, 11:49-60.
Khan A, Leventhal RM, Khan S, Brown WA. Severity of depression and response to antidepressants and placebo: an anlysis of the Food and Drug Administration data base. J Clin Psychopharmacol. 2002; 22:1-6.
Gilles C, Schunk T, Erb G. Human models as tools in the development of psychotropic drugs. Dialogues Clin Neurosci. 2002; 4:377-387.
Lebowitz BD. A public health approach to clinical therapeutics in psychiatry: directions for new reasearch. Dialogues Clin Neurosci. 2000; 2:309-314.
Lipska BK, Aultman JM, Verma A, Weinberger DR, Moghaddam B. Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacol. 2002; 27:47-54.
Canadian Psychological Association. Canadian Code of Ethics for Psychologists – Third Edition. Ottawa – Canada: Canadian Psychological Association, 2000.
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
Tel: (001)347-983-5186